Research progress of cannabidiol in the treatment of epilepsy
10.3760/cma.j.issn.1006-7876.2019.07.013
- VernacularTitle:大麻二酚在癫痫治疗中的研究进展
- Author:
Zhen LI
1
;
Yan WANG
;
Patrick KWAN
Author Information
1. 青岛大学附属医院神经内科 266000
- Keywords:
Epilepsy;
Marijuana;
Cannabidiol;
Antiepileptic drugs
- From:
Chinese Journal of Neurology
2019;52(7):586-591
- CountryChina
- Language:Chinese
-
Abstract:
In the treatment of refractory epilepsy,especially in Dravet syndrome and Lennox-Gastaut syndrome,cannabidiol,an anticonvulsant component of marijuana,has shown significant efficacy and safety.However,its mechanism of action and interaction with other drugs are still unclear.For refractory patients who have been treated with a variety of antiepileptic drugs,cannabidiol makes their treatment more promising but also more complicated.This review focuses on the mechanism of cannabidiol and its clinical research progress in the treatment of refractory epilepsy.
